Subcutaneous Biologics Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026
Request Sample Copy of this Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/74
Increase in Awareness and the number of Diagnosed cases will Drive Demand in Developing Regions
In terms of geography, the global market for subcutaneous biologics is segmented into four major regions, namely, North America, Europe, Asia-Pacific (APAC) and Rest of the World (RoW). There is huge healthcare spending in countries such as United States and Canada, and high prevalence of diseases such as rheumatoid arthritis and breast cancer. The Centers for Disease Control and Prevention (CDC) estimate that the current prevalence of rheumatoid arthritis (nearly 50 million Americans in 2012) will increase to 78 million by 2040. The disease also affects nearly 300,000 children in the U.S. according to RheumatoidArthritis.org. In the European region, EU-5 countries (Germany, France, United Kingdom, Italy and Spain) are the most potential market owing well established economy of these regions. Convenient drug delivery format is also in demand in developing regions such as Asia Pacific and Latin America where therapy compliance is a major issue. Large undiagnosed population, inadequate access to medicines and affordability issues hinder the market growth for subcutaneous biologics in developing regions.
Download PDF Copy of this Business Report @ https://www.coherentmarketinsights.com/insight/request-pdf/74
Key Vendors of Subcutaneous Biologics Market include Genentech Inc., Biogen Idec, F. Hoffmann-La Roche AG, Amgen, Inc., Eisai, Inc., AbbVie, Inc., Pfizer Ltd., Takeda Pharmaceutical Company Ltd. and Bristol-Myers Squibb.
Subcutaneous Biologics Market Taxonomy
Humira (Adalimumab), MabThera/Rituxan (Rituximab), Zytux (Rituximab), Stelara (ustekinumab), Enbrel (Etanercept)., Neulasta (filgrastim), ORENCIA (abatacept), RoACTEMRA (tocilizumab) and Herceptin (Trastuzumab) are among the major commercially available biologics that are administered through subcutaneous route. F. Hoffmann-La Roche AG announced the European Commission (EU) approval of its subcutaneous formulation of RoACTEMRA (tocilizumab) in April 2014. Amgen launched Neulasta delivery kit in 2015 to automate the delivery of drug and preventing infection in cancer patients. The global market for subcutaneous biologics has been segmented by the aforementioned biologic brands.
On the basis of subcutaneous drug delivery systems, the market is categorized as:
Drug reconstitution delivery systems.
The subcutaneous biologics market is also analyzed based on the applications as follows:
Ask for TOC @ https://www.coherentmarketinsights.com/ongoing-insight/toc/74
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Subcutaneous Biologics Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026 here
News-ID: 1218699 • Views: 238
More Releases from CMI - Biotechnology Industry
Global Human Microbiome Market - Merck & Co. Inc., Affymetrix Inc., Vithera Phar …
Microbial cells outnumber the human cells in the ratio 10:1 in a health human body. Human microbiome is the study of microbes present in the human body. These are beneficial microbes that carry out functions not performed by any gene in the human DNA and hence, they play a very important role in the human body. For example, these microbes produce certain vitamins that our body cannot make, breakdown our
Next Generation Sequencing Market - Global Industry Insights, Trends, Outlook, a …
Next Generation Sequencing (NGS) is a powerful, flexible, and indispensable biological tool that is used in several areas of biological study. NGS technologies help in generating genome-wide sequence data in a couple of days. These technologies are highly parallelized allowing to sequence thousands to millions of molecules at the same time. The main advantage of these platforms is determination of the sequenced data from amplified single DNA fragments, avoiding the
Digital Genome Market - Global Industry Insights, Trends, Outlook, and Opportuni …
Digital genome is the complete digital set of genes or genetic material present in a cell or organism. Genome is the branch of biology that deals with the study of genes and their functions. Digital genome allows the conversion of this large volume of data into products and services. A digital genome act as a pivot table that allows instant access to trait combinations to solve seemingly endless custom queries.
Plant Stem Cell Market - Global Industry Insights, Trends, Outlook, and Opportun …
Plant stem cells are undifferentiated cells within the meristems of plants. Plant stem cells serve as the origin of plant vitality as they maintain themselves and provide a steady supply of precursor cells to form various tissues and organs in plants. Plant stem cells are characterized by two distinctive properties namely its ability to create differentiated cell types and to self-renew such that the number of stem cells remain stable.
More Releases for Biologic
Biologic Injectors Market Insights, Forecast to 2028
Biologic injectors are the injecting devices used to deliver drugs and other substances for biological purposes. Biological products such as drugs, growth hormones, antibodies and other complex biological molecules are administered into the body of an organism through biologic injectors. Biologic injectors are basically used for the treatment of various diseases. Biologic injectors offer different methods of administration such as simple piston, gas, jet and others. They can also be used
Biologic and Medical Imaging Reagents: Global Healthcare Update 2018
Press Release – 10 Jan 2019 Research and Development News -- . . Latest Update "Biologic and Medical Imaging Reagents: Global Markets" with Industries Survey | Global Current Growth and Future. ' ' Report Highlights The global market for biological imaging reagents was valued at $13.2 billion in 2016. This market will grow from $14.4 billion in 2017 to nearly $23.9 billion by 2022 with a compound annual growth rate (CAGR) of 10.6% for the
Biologic Therapeutics Market Insights & Outlook on Industry 2025
Global Biologic Therapeutics Market: Snapshot The branch of science that deals with manufacturing medicines and pharmaceutical products based on biological origins is called biological therapeutics. Any pharmaceutical drug product manufactured from semi-synthesized and biological sources is included under this field. Owing to rapid advances experienced by this sector, a distinct biologic therapeutics market has formed. This market is mainly being driven by a rising demand for better healthcare treatments occurring all
Biologic Therapeutics Market Geographical Outlook by 2025
Global Biologic Therapeutics Market: Overview The global biologic therapeutics market is predicted to benefit from the rising applications of biological products. Biological products could be made of sugars, nucleic acids, proteins, or complex combinations of these substances, or may be living components such as cells and tissues. Biological products are used to prevent diseases, diagnose diseases, or treat or cure medical conditions. Global Biologic Therapeutics Market: Key Trends and Opportunities First and foremost,
Human Hepatitis B Immunoglobulin (IM) Market 2017 - Shanghai RAAS, Hualan Biolog …
Apex Research, recently published a detailed market research study focused on the "Human Hepatitis B Immunoglobulin (IM) Market" across the global, regional and country level. The report provides 360° analysis of "Human Hepatitis B Immunoglobulin (IM) Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Human Hepatitis B Immunoglobulin (IM) industry, and
Global Biologic Drugs Sales Market Report 2017
In this report, the global Biologic Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Biologic Drugs for these regions, from 2012 to 2022 (forecast),